A summary of clinical studies elucidating the use of antidiabetics against glaucoma is given in Table 2
Users in the Netherlands may contact the Autoriteit Persoonsgegevens (AP) at www.autoriteitpersoonsgegevens.nl
Thyroid concerns Animal studies suggest a possible link to thyroid tumors, but this has not been confirmed in humans
The classic "I am well-behaved today" salad
The main elimination routs of semaglutide are through urine and feces
Here's the current landscape: Brand Name Oral Semaglutide (Wegovy pill): Novo Nordisk announced a limited-time price of $149/month for the starting dose Higher doses (25mg) may cost more Launched in January 2026 Additional costs may apply such as labs, consultations, shipping and membership Brand Name Injectable GLP-1s: Wegovy: $1,000-1,500/month without insurance Ozempic: $900-1,000/month without insurance Mounjaro/Zepbound: $1,000-1,400/month without insurance Compounded Injectable GLP-1s: Affinity Whole Health: Starting at $299/month for compounded semaglutide Includes medications, supplies, shipping, and ongoing support Significant savings compared to brand names Compounded ODT Formulations: Prices vary widely, typically $299-449/month for compounded semaglutide or tirzepatide ODTs Generally more expensive than compounded injectables Available through compounding pharmacies Currently, compounded injectable medications from FDA-registered facilities remain the most cost-effective option for most patients seeking GLP-1 therapy
